Literature DB >> 25419424

Factors related to survival rates for breast cancer patients.

Guizhi Dong1, Deguang Wang1, Xiaolin Liang2, Huiquan Gao1, Ling Wang1, Xinjiao Yu3, Jingjun Liu1.   

Abstract

This study is to analyze the relationship between clinical parameters and prognosis and survival rates of breast cancer patients. A total of 1541 cases of breast cancer were retrospectively reviewed with respect to clinical parameters and the correlation with prognosis and survival rates. Among these patients, follow-up investigation was performed for 1381 cases. Clinical parameters including disease sites (the lesion quadrant), incidences, the number of axillary lymph node metastasis, maximum diameter of tumor, tumor regional lymph node metastasis (TNM) stages, pathological types were investigated. The estrogen receptor, progesterone receptor, Human Epidermal Growth Factor Receptor-2 levels were correlated with long term disease-free survival. Lymph node metastases, tumor diameter, TNM stage, and hormone receptor status are correlated with survival rates of breast cancer patients.

Entities:  

Keywords:  Breast cancer; breast cancer prognosis factors; clinical parameters; retrospective analysis

Year:  2014        PMID： 25419424      PMCID： PMC4238527     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN： 1940-5901


  13 in total

1.  Age effects on survival from early breast cancer in clinical settings in Australia.

Authors:  David M Roder; Primali de Silva; Helen M Zorbas; James Kollias; Peter L Malycha; Chris M Pyke; Ian D Campbell
Journal:  ANZ J Surg       Date:  2012-07-08       Impact factor: 1.872

2.  [Differences and clinical significance of receptor expression between primary and locally recurrent breast tumor tissues].

Authors:  Xiang-min Ma; Yun-wei Han; Jiao Zhang; Wen-jing Cui; Xin Wang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2013-05

3.  [Epidemiological and biologic profile of breast cancer in Fez-Boulemane, Morocco].

Authors:  F Abbass; S Bennis; K Znati; Y Akasbi; J K Amrani; O El Mesbahi; A Amarti
Journal:  East Mediterr Health J       Date:  2011-12       Impact factor: 1.628

4.  Clinical roundtable monograph. Current treatment options for metastatic breast cancer: what now?

Authors:  Hope S Rugo; Joyce A O'Shaughnessy; Edith A Perez
Journal:  Clin Adv Hematol Oncol       Date:  2011-11

5.  Platinum-based chemotherapy in triple-negative breast cancer.

Authors:  B Sirohi; M Arnedos; S Popat; S Ashley; A Nerurkar; G Walsh; S Johnston; I E Smith
Journal:  Ann Oncol       Date:  2008-06-20       Impact factor: 32.976

6.  Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.

Authors:  Fiona M Blows; Kristy E Driver; Marjanka K Schmidt; Annegien Broeks; Flora E van Leeuwen; Jelle Wesseling; Maggie C Cheang; Karen Gelmon; Torsten O Nielsen; Carl Blomqvist; Päivi Heikkilä; Tuomas Heikkinen; Heli Nevanlinna; Lars A Akslen; Louis R Bégin; William D Foulkes; Fergus J Couch; Xianshu Wang; Vicky Cafourek; Janet E Olson; Laura Baglietto; Graham G Giles; Gianluca Severi; Catriona A McLean; Melissa C Southey; Emad Rakha; Andrew R Green; Ian O Ellis; Mark E Sherman; Jolanta Lissowska; William F Anderson; Angela Cox; Simon S Cross; Malcolm W R Reed; Elena Provenzano; Sarah-Jane Dawson; Alison M Dunning; Manjeet Humphreys; Douglas F Easton; Montserrat García-Closas; Carlos Caldas; Paul D Pharoah; David Huntsman
Journal:  PLoS Med       Date:  2010-05-25       Impact factor: 11.069

7.  Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer.

Authors:  Reiki Nishimura; Tomofumi Osako; Yasuyuki Nishiyama; Rumiko Tashima; Masahiro Nakano; Mamiko Fujisue; Yasuo Toyozumi; Nobuyuki Arima
Journal:  Oncology       Date:  2013-07-17       Impact factor: 2.935

8.  Prognostic significance of a positive axillary lymph node fine-needle aspirate in patients with invasive breast carcinoma.

Authors:  Martin C Chang; Jaime M Escallon; Terence J Colgan
Journal:  Cancer Cytopathol       Date:  2013-09-18       Impact factor: 5.284

9.  Breast cancer clinical characteristics and outcomes in Trinidad and Tobago.

Authors:  Marlene Camacho-Rivera; Camille Ragin; Veronica Roach; Tricia Kalwar; Emanuela Taioli
Journal:  J Immigr Minor Health       Date:  2015-06

10.  Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.

Authors:  Solange Torchia Carvalho; Monica Maria Stiepcich; José Humberto Fregnani; Sueli Nonogaki; Rafael Rocha; Fernando Augusto Soares
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365
View more
  10 in total

1.  Clinical staging in bitches with mammary tumors: Influence of type and histological grade.

Authors:  Lígia F Gundim; Camila P de Araújo; William T Blanca; Ednaldo C Guimarães; Alessandra A Medeiros
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

2.  Dual-Time 18F-FDG PET/CT Imaging in Initial Locoregional Staging of Breast Carcinoma: Comparison with Conventional Imaging and Pathological Prognostic Factors.

Authors:  Aynur Ozen; Serdar Altinay; Ozgul Ekmekcioglu; Ramazan Albayrak; Ali Muhammedoglu; Hakan Yigitbas; Eylem Bastug; Atilla Celik
Journal:  Indian J Surg       Date:  2016-04-23       Impact factor: 0.656

3.  Clinicopathological Factors Affecting Breast Cancer Survival in Jamaican Women: A Retrospective Review.

Authors:  Kemba A Peters; Patrick O Roberts; Derria A Cornwall; Derek I Mitchell; Rory K Thompson
Journal:  J Racial Ethn Health Disparities       Date:  2022-03-09

4.  The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines.

Authors:  Misagh Majidi; Sahar Safaee; Mohammad Amini; Amir Baghbanzadeh; Khalil Hajiasgharzadeh; Shahriar Hashemzadeh; Siamak Sandoghchian Shotorbani; Ahad Mokhtarzadeh; Behzad Baradaran
Journal:  Med Oncol       Date:  2021-10-23       Impact factor: 3.064

5.  Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer.

Authors:  Jenny Lin; Leanne Goldstein; Amanda Nesbit; Mike Y Chen
Journal:  World Neurosurg       Date:  2015-08-07       Impact factor: 2.104

6.  Development and validation of a novel nomogram for predicting distant metastasis-free survival among breast cancer patients.

Authors:  Yan Wang; Yaping Yang; Zhengbo Chen; Teng Zhu; Jiannan Wu; Fengxi Su; Heran Deng
Journal:  Ann Transl Med       Date:  2019-10

7.  RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.

Authors:  Alaa Zare; Alexandra Petrova; Mehdi Agoumi; Heather Amstrong; Gilbert Bigras; Katia Tonkin; Eytan Wine; Shairaz Baksh
Journal:  Cancers (Basel)       Date:  2018-06-05       Impact factor: 6.639

8.  Association between Pre-Existing Sleep Disorders and Survival Rates of Patients with Breast Cancer.

Authors:  Yen-Chang Chen; Wan-Ming Chen; Ming-Feng Chiang; Ben-Chang Shia; Szu-Yuan Wu
Journal:  Cancers (Basel)       Date:  2022-02-04       Impact factor: 6.639

9.  Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling.

Authors:  Zaid H Maayah; Shingo Takahara; Abrar S Alam; Mourad Ferdaoussi; Gopinath Sutendra; Ayman O S El-Kadi; John R Mackey; Edith Pituskin; D Ian Paterson; Jason R B Dyck
Journal:  BMC Cancer       Date:  2020-08-12       Impact factor: 4.430

10.  Application of Censored Quantile Regression to Determine Overall Survival Related Factors in Breast Cancer.

Authors:  Javad Faradmal; Ghodratollah Roshanaei; Maryam Mafi; Abdolazim Sadighi-Pashaki; Manoochehr Karami
Journal:  J Res Health Sci       Date:  2016
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.